MedBlog

CKM syndrome: The intersection of obesity, diabetes, heart and kidney diseases

Obesity, heart and kidney diseases, and diabetes are all connected, and now that the American Heart Association has formalized CKM syndrome, it could change the future of cardiology.

Amit Khera, M.D.

February 1, 2024

New immunotherapy can prevent kidney cancer recurrence after surgery: Is it right for you?

The FDA has approved pembrolizumab immunotherapy, the first treatment to lower kidney cancer recurrence risk after surgery. UT Southwestern's Dr. Hans Hammers helps patients explore its benefits and risks.

Hans Hammers, M.D., Ph.D.

March 18, 2022

Dual epidemics in Texas: Navigating kidney transplantation during COVID-19

Patients with kidney disease and living donors face new challenges in the wake of COVID-19. Get answers to pre- and post-transplant FAQs in this MedBlog.

David Wojciechowski, D.O.

June 10, 2020

The Team That's Doubling Cancer Survival Rates

Hans Hammers, M.D., Ph.D. / James Brugarolas, M.D., Ph.D.

November 9, 2018